Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05763004 |
| Title | A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With a PD-1 Monoclonal Antibody in Advanced Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | ImmunOs Therapeutics AG |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Monash Health Medical Center | NOT_YET_RECRUITING | Clayton | Australia | Details | ||
| Austin Health / Cancer Clinical Trials Center | NOT_YET_RECRUITING | Heidelberg | Australia | Details | ||
| Alfread Health | NOT_YET_RECRUITING | Melbourne | Australia | Details | ||
| Peter MacCallum Cancer Center | NOT_YET_RECRUITING | Melbourne | Australia | Details | ||
| Linear Clinical Research | RECRUITING | Perth | Australia | Details |